The top 100 biotech VCs: Who’s staying at the table and what do they want now? – Endpoints News

by

  1. The top 100 biotech VCs: Who’s staying at the table and what do they want now? Endpoints News
  2. Aera Therapeutics Launches with $193 Million in Financing to Enable and Advance the Next Generation of Transformative Genetic Medicines businesswire.com
  3. Investors bet big on Feng Zhang’s new startup, out to solve one of gene editing’s most vexing problems The Boston Globe
  4. CRISPR pioneer Feng Zhang launches new genetic delivery startup with $193 million STAT
  5. Alnylam vet heads up new gene biotech with $193M in hand FierceBiotech
  6. View Full Coverage on Google News

Read original article here

Leave a Comment